BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38171083)

  • 1. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
    Yang Y; Yue C; Li Y; Piao Y
    Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytological diagnosis of olfactory neuroblastoma at metastatic sites, with emphasis on role of insulinoma-associated protein 1 immunocytochemistry.
    Roy D; Sriram S; Kakkar A; Kumar R; Kaur K; Jain D; Sharma A; Thakar A
    Diagn Cytopathol; 2023 Feb; 51(2):146-152. PubMed ID: 36369994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
    Minami K; Jimbo N; Tanaka Y; Ogawa H; Hokka D; Nishio W; Yoshimura M; Itoh T; Maniwa Y
    J Surg Oncol; 2020 Aug; 122(2):243-253. PubMed ID: 32346887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
    Hou T; Gan Q; Joseph CT; Sun X; Gong Y
    Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
    Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
    Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
    Kuji S; Watanabe R; Sato Y; Iwata T; Hirashima Y; Takekuma M; Ito I; Abe M; Nagashio R; Omae K; Aoki D; Kameya T
    Gynecol Oncol; 2017 Feb; 144(2):384-390. PubMed ID: 27908529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and non-neuroendocrine role of INSM1 in small cell lung cancer.
    Xu X; Wang G; Duan Y; Huo Z
    Pathol Res Pract; 2022 Jan; 229():153693. PubMed ID: 34826740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of microvessel density and its correlation with clinicopathological features in human olfactory neuroblastoma.
    Wu L; An J; Liu H
    Clin Neuropathol; 2022; 41(3):114-121. PubMed ID: 35142285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients.
    Takase Y; Naito Y; Okabe Y; Ishida Y; Yamaguchi T; Abe H; Murata K; Ito T; Tanigawa M; Kawahara A; Yano H; Akiba J
    Cytopathology; 2019 Mar; 30(2):194-200. PubMed ID: 30290028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
    Kim D; Viswanathan K; Goyal A; Rao R
    Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
    Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
    Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database.
    Duo GS; Feng JL; Zhang ZY; Wang LJ
    Cancer Radiother; 2022 Sep; 26(5):663-669. PubMed ID: 35249817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts.
    González I; Lu HC; Sninsky J; Yang C; Bishnupuri K; Dieckgraefe B; Cao D; Chatterjee D
    Histopathology; 2019 Oct; 75(4):568-577. PubMed ID: 31077609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.